|
|
Volumn 48, Issue 4, 2008, Pages 505-506
|
|
Interaction of hepatitis B and C viruses in patients infected with HIV
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIDANOSINE;
EFAVIRENZ;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
LAMIVUDINE;
NEVIRAPINE;
STAVUDINE;
VIRUS ANTIBODY;
VIRUS DNA;
VIRUS RNA;
ZIDOVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIBODY BLOOD LEVEL;
ANTIVIRAL THERAPY;
BLOOD DONOR;
DRUG EFFECT;
DRUG EFFICACY;
DRUG USE;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MIXED INFECTION;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RECIPIENT;
UNSPECIFIED SIDE EFFECT;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
ADULT;
BLOOD;
FEMALE;
GENETICS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
ISOLATION AND PURIFICATION;
MALE;
VIROLOGY;
ADULT;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
DNA, VIRAL;
FEMALE;
HEPACIVIRUS;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HIV INFECTIONS;
HUMANS;
LAMIVUDINE;
MALE;
RNA, VIRAL;
|
|
EID: 50649110098
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/QAI.0b013e31816de23c Document Type: Letter |
|
Times cited : (12)
|
|
References (4)
|
